Cargando…
Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells
Overexpression of ATP-binding cassette (ABC) transporters is often linked to multidrug resistance (MDR) in cancer chemotherapies. P-glycoprotein (P-gp) is one of the best studied drug transporters associated with MDR. There are currently no approved drugs available for clinical use in cancer chemoth...
Autores principales: | Nanayakkara, Amila K., Follit, Courtney A., Chen, Gang, Williams, Noelle S., Vogel, Pia D., Wise, John G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772368/ https://www.ncbi.nlm.nih.gov/pubmed/29343829 http://dx.doi.org/10.1038/s41598-018-19325-x |
Ejemplares similares
-
Prolonged inhibition of P-glycoprotein after exposure to chemotherapeutics increases cell mortality in multidrug resistant cultured cancer cells
por: Nanayakkara, Amila K., et al.
Publicado: (2019) -
In silico identified targeted inhibitors of P-glycoprotein overcome multidrug resistance in human cancer cells in culture
por: Follit, Courtney A, et al.
Publicado: (2015) -
Infigratinib (BGJ 398), a Pan-FGFR Inhibitor, Targets P-Glycoprotein and Increases Chemotherapeutic-Induced Mortality of Multidrug-Resistant Tumor Cells
por: Boichuk, Sergei, et al.
Publicado: (2022) -
Transport of Alzheimer’s associated amyloid-β catalyzed by P-glycoprotein
por: McCormick, James W., et al.
Publicado: (2021) -
Branebrutinib (BMS-986195), a Bruton’s Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents
por: Wu, Chung-Pu, et al.
Publicado: (2021)